T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.
about
Lung inflammation caused by inhaled toxicants: a reviewCOPD immunopathologyImmune Dysfunction in Patients with Chronic Obstructive Pulmonary DiseaseCigarette Smoke Disturbs the Survival of CD8+ Tc/Tregs Partially through Muscarinic Receptors-Dependent Mechanisms in Chronic Obstructive Pulmonary DiseaseLower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzaeImbalance of dendritic cell co-stimulation in COPD.Probing Cellular and Molecular Mechanisms of Cigarette Smoke-Induced Immune Response in the Progression of Chronic Obstructive Pulmonary Disease Using Multiscale Network Modeling.COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link.Dysregulation of Antiviral Function of CD8(+) T Cells in the Chronic Obstructive Pulmonary Disease Lung. Role of the PD-1-PD-L1 Axis.Chronic NF-κB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungs.Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease.PD-1(+) and Foxp3(+) T cell reduction correlates with survival of HCC patients after sorafenib therapyTGF-β/BAMBI pathway dysfunction contributes to peripheral Th17/Treg imbalance in chronic obstructive pulmonary diseaseJanus-faced Acrolein prevents allergy but accelerates tumor growth by promoting immunoregulatory Foxp3+ cells: Mouse model for passive respiratory exposureEpigenetic targets for novel therapies of lung diseases.The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi).Update in Chronic Obstructive Pulmonary Disease 2014.Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.Increased CTLA-4+ T cells may contribute to impaired T helper type 1 immune responses in patients with chronic obstructive pulmonary disease.Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib.Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.Infiltration of IL-17-Producing T Cells and Treg Cells in a Mouse Model of Smoke-Induced Emphysema.Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections.Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease.Glucagon-like peptide-1 receptor (GLP-1R) signaling ameliorates dysfunctional immunity in COPD patientsThe Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
P2860
Q26744356-2B508681-8CB4-4034-93FC-E2BCA2CFEE75Q26749575-2C3A7993-61F5-43EE-836A-7B1C83961A77Q28083093-2649C437-0B5F-4764-A1F2-D564A70EC6BDQ28552804-8C2B8065-9E2E-4093-B6F4-7BAA25ED0B6DQ34386841-CFB04E4F-522C-4CF6-B47A-115870920038Q35105292-A52CA200-FABC-48BD-A8A8-B00BB4EF044BQ36145085-03409756-48F7-4C8F-9893-DCDC8893489EQ36546997-CFB87CE3-C0AE-4CAA-8CCB-762FFD0060D2Q36778601-784332B0-2597-4FCB-A9CC-53B0B9FCCBDBQ36905694-D52F6FC3-C6AA-4DDF-8F4E-0AA2C3C6D1A1Q36937623-232B4752-C86B-4E47-A2B8-F3EA4943146CQ37179971-F7F8F590-5F37-4CBF-B88A-8943FFA35CD2Q37195537-6C2D50A8-EC10-44A4-AA06-730435D2B75FQ37717309-913FC369-016E-4ED1-B431-FC988FA4E400Q38275276-13A8169F-0392-4D0D-AC94-5D764C9AA14FQ38538384-CCF5FE46-F865-45C2-97B5-25CFB7971D80Q38620368-CF2E38E3-A9ED-4DF1-BC34-9A2738B61B67Q38679715-0B25FEBB-0F27-48FC-B24B-7CA67A0A9ABCQ38837749-D5653A42-F7F8-4A19-868D-CB7E18764D8DQ40235118-B9AD1B89-F0E3-405B-9D11-4879AF7B72EFQ40335666-9812B8E6-EA40-4AF2-B049-29AE94FB36E6Q41605285-B4041759-7FD3-4369-92FC-162146599B46Q41625103-DAD2D4C8-648A-4DFA-B255-8C2CCF08D60AQ48313511-1BEB12DD-E471-4508-8130-12A4B2F4717BQ51527646-BCE9613F-249C-4344-9B22-7185E894CC8BQ54253074-D0748DA6-EED5-44A7-A132-B3EAB1313EA1Q55048565-CF4F895D-AB3D-4FBC-B61A-AB40920E6C96Q57817179-2348AEF6-F7C1-47A2-8C8E-67FCB6AF0728Q59130095-520FC4CC-F5FC-465E-AE63-6AEF20A45DC0
P2860
T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
T-regulatory cells and program ...... obstructive pulmonary disease.
@ast
T-regulatory cells and program ...... obstructive pulmonary disease.
@en
T-regulatory cells and program ...... obstructive pulmonary disease.
@nl
type
label
T-regulatory cells and program ...... obstructive pulmonary disease.
@ast
T-regulatory cells and program ...... obstructive pulmonary disease.
@en
T-regulatory cells and program ...... obstructive pulmonary disease.
@nl
prefLabel
T-regulatory cells and program ...... obstructive pulmonary disease.
@ast
T-regulatory cells and program ...... obstructive pulmonary disease.
@en
T-regulatory cells and program ...... obstructive pulmonary disease.
@nl
P2093
P2860
P1476
T-regulatory cells and program ...... obstructive pulmonary disease.
@en
P2093
Amit Anand Lugade
Austin Miller
Ganapathi Iyer Parameswaran
Sanjay Sethi
Suresh Gopi Kalathil
Vandana Pradhan
Yasmin Thanavala
P2860
P356
10.1164/RCCM.201312-2293OC
P407
P577
2014-07-01T00:00:00Z